Some of the risks of prostate screening include the false positive rate. The false positive rate is the number of men with an abnormal PSA, who do not have cancer. For some years a cutoff of 4.0 ng/mL ...

Men from the placebo group whose PSA had never exceeded 4.0 ng/ml, who had never previously undergone a prostate biopsy or transurethral prostate resection, and who had consistently normal results ...

Your prostate makes this PSA all the time, so a small amount of the protein (usually resulting in a reading of less than 4 ng/mL) is normal. Because cancer cells produce extra PSA, a higher ...

Prostate-specific antigen (PSA) is a protein the prostate produces from both normal and abnormal cells. The prostate is a ...

Screening PSA levels at aged 65-69 may inform the decision to continue or discontinue prostate cancer screening after age 70 years, regardless of patient race and ethnicity. The absolute risks of ...

At-home tests for men worried about prostate cancer can give inconsistent and inaccurate results, BBC News has found. The ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

It can help them see how well treatment is working. Prostate specific antigen (PSA) is a protein produced by both normal and cancerous prostate cells. It's normal for all men to have some PSA in their ...

In summary, when an asymptomatic man presents with a modestly elevated PSA level (<10 ng/ml) and a normal digital rectal examination, the most appropriate recommendation is to reassure the patient ...

There is no national screening programme for prostate cancer in the UK. This is because there isn’t a reliable test that can pick up prostate cancer that needs treatment at an early stage. Researchers ...